NASDAQ: ALZN
Alzamend Neuro Inc Stock Ownership - Who owns Alzamend Neuro?

Insider buying vs selling

Have Alzamend Neuro Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
William B. HorneDirector2025-03-263,334$0.99
$3.28kBuy
Milton C. Ault IiiDirector2025-03-212,905$1.02
$2.97kBuy
David J. KatzoffChief Financial Officer2025-03-215,000$1.01
$5.05kBuy
William B. HorneDirector2025-03-205,000$0.98
$4.89kBuy
William B. HorneDirector2025-03-1810,000$0.06
$600.00Buy
Milton C. Ault IiiDirector2025-03-185,000$0.96
$4.81kBuy
William B. HorneDirector2025-03-185,000$0.97
$4.85kBuy
Milton C. Ault IiiDirector2025-03-12100$0.68
$68.40Buy
Milton C. Ault IiiDirector2024-08-0675$2.75
$206.25Buy
Milton C. Ault IiiDirector2024-07-3125$3.74
$93.43Buy

1 of 1

ALZN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALZN insiders and whales buy or sell their stock.

ALZN Shareholders

What type of owners hold Alzamend Neuro Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Milton C. Ault Iii533.35%35,187,810$23.40MInsider
Jeffrey Oram1.52%100,000$66.50kInsider
Andrew H. Woo1.52%100,000$66.50kInsider
Mark Gustafson0.91%60,000$39.90kInsider
Stephan Jackman0.69%45,500$30.26kInsider
Geode Capital Management LLC0.51%33,540$22.30kInstitution
Citadel Advisors LLC0.46%30,638$20.37kInstitution
William B. Horne0.45%30,000$19.95kInsider
Truist Financial Corp0.23%15,498$10.31kInstitution
Renaissance Technologies LLC0.23%15,000$9.98kInstitution

1 of 3

ALZN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALZN0.32%99.68%Net BuyingNet Buying
XBIO2.15%97.85%
SONN1.92%98.08%
PTN14.18%72.81%Net Selling
VRAX1.45%0.00%

Alzamend Neuro Stock Ownership FAQ

Who owns Alzamend Neuro?

Alzamend Neuro (NASDAQ: ALZN) is owned by 1.72% institutional shareholders, 538.60% Alzamend Neuro insiders, and 0.00% retail investors. Milton C. Ault Iii is the largest individual Alzamend Neuro shareholder, owning 35.19M shares representing 533.35% of the company. Milton C. Ault Iii's Alzamend Neuro shares are currently valued at $23.22M.

If you're new to stock investing, here's how to buy Alzamend Neuro stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.